Literature DB >> 26901704

Allogeneic transplantation for multiple myeloma: yes, no or maybe?

B Bruno1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26901704     DOI： 10.1038/bmt.2016.12

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  18 in total

1.  Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma.

Authors:  Philippe Moreau; Frédéric Garban; Michel Attal; Mauricette Michallet; Gérald Marit; Cyrille Hulin; Lotfi Benboubker; Chantal Doyen; Mohamad Mohty; Ibrahim Yakoub-Agha; Serge Leyvraz; Philippe Casassus; Hervé Avet-Loiseau; Laurent Garderet; Claire Mathiot; Jean-Luc Harousseau
Journal:  Blood       Date:  2008-11-01       Impact factor: 22.113

2.  Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma.

Authors:  Luisa Giaccone; Barry Storer; Francesca Patriarca; Marcello Rotta; Roberto Sorasio; Bernardino Allione; Fabrizio Carnevale-Schianca; Moreno Festuccia; Lucia Brunello; Paola Omedè; Sara Bringhen; Massimo Aglietta; Alessandro Levis; Nicola Mordini; Andrea Gallamini; Renato Fanin; Massimo Massaia; Antonio Palumbo; Giovannino Ciccone; Rainer Storb; Ted A Gooley; Mario Boccadoro; Benedetto Bruno
Journal:  Blood       Date:  2011-04-13       Impact factor: 22.113

3.  Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantation.

Authors:  I Ahmad; R LeBlanc; S Cohen; S Lachance; T Kiss; G Sauvageau; D C Roy; L Busque; J-S Delisle; N Bambace; L Bernard; W Sabry; J Roy
Journal:  Bone Marrow Transplant       Date:  2015-12-21       Impact factor: 5.483

Review 4.  Allogeneic stem cell transplantation in multiple myeloma: immunotherapy and new drugs.

Authors:  Moreno Festuccia; Massimo Martino; Federica Ferrando; Giuseppe Messina; Tiziana Moscato; Roberta Fedele; Mario Boccadoro; Luisa Giaccone; Benedetto Bruno
Journal:  Expert Opin Biol Ther       Date:  2015-04-12       Impact factor: 4.388

5.  Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myeloma.

Authors:  Nicolaus Kröger; Anita Badbaran; Tatjana Zabelina; Francis Ayuk; Christine Wolschke; Haefaa Alchalby; Evgeny Klyuchnikov; Djordje Atanackovic; Georgia Schilling; Timon Hansen; Sabine Schwarz; Marion Heinzelmann; Silke Zeschke; Ulrike Bacher; Thomas Stübig; Boris Fehse; Axel R Zander
Journal:  Biol Blood Marrow Transplant       Date:  2012-10-16       Impact factor: 5.742

6.  A comparison of allografting with autografting for newly diagnosed myeloma.

Authors:  Benedetto Bruno; Marcello Rotta; Francesca Patriarca; Nicola Mordini; Bernardino Allione; Fabrizio Carnevale-Schianca; Luisa Giaccone; Roberto Sorasio; Paola Omedè; Ileana Baldi; Sara Bringhen; Massimo Massaia; Massimo Aglietta; Alessandro Levis; Andrea Gallamini; Renato Fanin; Antonio Palumbo; Rainer Storb; Giovannino Ciccone; Mario Boccadoro
Journal:  N Engl J Med       Date:  2007-03-15       Impact factor: 91.245

7.  Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.

Authors:  Marcello Rotta; Barry E Storer; Firoozeh Sahebi; Judith A Shizuru; Benedetto Bruno; Thoralf Lange; Edward D Agura; Peter A McSweeney; Michael A Pulsipher; Parameswaran Hari; Richard T Maziarz; Thomas R Chauncey; Frederick R Appelbaum; Mohamed L Sorror; William Bensinger; Brenda M Sandmaier; Rainer F Storb; David G Maloney
Journal:  Blood       Date:  2008-11-17       Impact factor: 22.113

8.  Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.

Authors:  Antonio Palumbo; Hervé Avet-Loiseau; Stefania Oliva; Henk M Lokhorst; Hartmut Goldschmidt; Laura Rosinol; Paul Richardson; Simona Caltagirone; Juan José Lahuerta; Thierry Facon; Sara Bringhen; Francesca Gay; Michel Attal; Roberto Passera; Andrew Spencer; Massimo Offidani; Shaji Kumar; Pellegrino Musto; Sagar Lonial; Maria T Petrucci; Robert Z Orlowski; Elena Zamagni; Gareth Morgan; Meletios A Dimopoulos; Brian G M Durie; Kenneth C Anderson; Pieter Sonneveld; Jésus San Miguel; Michele Cavo; S Vincent Rajkumar; Philippe Moreau
Journal:  J Clin Oncol       Date:  2015-08-03       Impact factor: 44.544

9.  Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo.

Authors:  Benedetto Bruno; Marcello Rotta; Francesca Patriarca; Daniele Mattei; Bernardino Allione; Fabrizio Carnevale-Schianca; Roberto Sorasio; Alessandro Rambaldi; Marco Casini; Matteo Parma; Pasqua Bavaro; Francesco Onida; Alessandro Busca; Luca Castagna; Edoardo Benedetti; Anna Paola Iori; Luisa Giaccone; Antonio Palumbo; Paolo Corradini; Renato Fanin; David Maloney; Rainer Storb; Ileana Baldi; Umberto Ricardi; Mario Boccadoro
Journal:  Blood       Date:  2008-12-08       Impact factor: 22.113

10.  Lenalidomide after stem-cell transplantation for multiple myeloma.

Authors:  Philip L McCarthy; Kouros Owzar; Craig C Hofmeister; David D Hurd; Hani Hassoun; Paul G Richardson; Sergio Giralt; Edward A Stadtmauer; Daniel J Weisdorf; Ravi Vij; Jan S Moreb; Natalie Scott Callander; Koen Van Besien; Teresa Gentile; Luis Isola; Richard T Maziarz; Don A Gabriel; Asad Bashey; Heather Landau; Thomas Martin; Muzaffar H Qazilbash; Denise Levitan; Brian McClune; Robert Schlossman; Vera Hars; John Postiglione; Chen Jiang; Elizabeth Bennett; Susan Barry; Linda Bressler; Michael Kelly; Michele Seiler; Cara Rosenbaum; Parameswaran Hari; Marcelo C Pasquini; Mary M Horowitz; Thomas C Shea; Steven M Devine; Kenneth C Anderson; Charles Linker
Journal:  N Engl J Med       Date:  2012-05-10       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.